Abstract:Cardiac deletion of BSCL2 causes ATGL overexpression, excessive fatty acid oxidation (FAO), drastic reduction of cardiac lipidome and ultimately energetic and contractile dysfunction in mice. Inhibiting FAO by partial ATGL deletion or trimetazidine and increasing lipid supply via high fat diet (HFD) feeding alleviate cardiac dysfunction caused by BSCL2 deficiency. BSCL2 is a novel protein indispensable for cardiac lipid metabolism and function.BackgroundHeart failure (HF) is one of the leading causes of death worldwide and is associated with cardiac metabolic perturbations. Human Type 2 Berardinelli‐Seip Congenital Lipodystrophy (BSCL2) disease is caused by mutations in the BSCL2 gene. Global lipodystrophic Bscl2−/− mice exhibit hypertrophic cardiomyopathy with reduced cardiac steatosis. Whether BSCL2 plays a direct role in regulating cardiac substrate metabolism and/or contractile function remains unknown.MethodsWe generated mice with cardiomyocyte‐specific deletion of Bscl2 (Bscl2cKO) and studied their cardiac substrate utilisation, bioenergetics, lipidomics and contractile function under baseline or after either a treatment regimen using fatty acid oxidation (FAO) inhibitor trimetazidine (TMZ) or a prevention regimen with high‐fat diet (HFD) feeding. Mice with partial ATGL deletion and cardiac‐specific deletion of Bscl2 were also generated followed by cardiac phenotyping.ResultsDifferent from hypertrophic cardiomyopathy in Bscl2−/− mice, mice with cardiac‐specific deletion of Bscl2 developed systolic dysfunction with dilation. Myocardial BSCL2 deletion led to elevated ATGL expression and FAO along with reduced cardiac lipid contents. Cardiac dysfunction in Bscl2cKO mice was independent of mitochondrial dysfunction and oxidative stress, but associated with decreased metabolic reserve and ATP levels. Importantly, cardiac dysfunction in Bscl2cKO mice could be partially reversed by FAO inhibitor TMZ, or prevented by genetic abolishment of one ATGL allele or HFD feeding. Lipidomic analysis further identified markedly reduced glycerolipids, glycerophospholipids, NEFA and acylcarnitines in Bscl2cKO hearts, which were partially normalised by TMZ or HFD.ConclusionsWe identified a new form of cardiac dysfunction with excessive lipid utilisation which ultimately causes cardiac substrate depletion and bioenergetics failure. Our findings also uncover a crucial role of BSCL2 in controlling cardiac lipid catabolism and contractile function and provide novel insights into metabolically treating energy‐starved HF using FAO inhibitor or HFD.

Deficiency of Adipose Triglyceride Lipase Induces Metabolic Syndrome and Cardiomyopathy in Zebrafish

Lipolysis and Lipophagy Play Individual and Interactive Roles in Regulating Triacylglycerol and Cholesterol Homeostasis and Mitochondrial Form in Zebrafish.

A zebrafish pparγ gene deletion reveals a protein kinase network associated with defective lipid metabolism

The Dysfunction of Hormone-Sensitive Lipase Induces Lipid Deposition and Reprogramming of Nutrient Metabolism in Fish.

Genomic knockout of alms1 in zebrafish recapitulates Alström syndrome and provides insight into metabolic phenotypes

Apoc2 loss-of-function zebrafish mutant as a genetic model of hyperlipidemia

GLUT12 deficiency during early development results in heart failure and a diabetic phenotype in zebrafish

Effect of adenosine monophosphate-activated protein kinase-p53-Krüppel-like factor 2a pathway in hyperglycemia-induced cardiac remodeling in adult zebrafish

Activation of Nkx2.5-Calr-p53 signaling pathway by hyperglycemia induces cardiac remodeling and dysfunction in adult zebrafish.

Activation of the Nkx2.5-Calr-p53 signaling pathway by hyperglycemia induces cardiac remodeling and dysfunction in adult zebrafish

The reduction of lipid-sourced energy production caused by ATGL inhibition cannot be compensated by activation of HSL, autophagy, and utilization of other nutrients in fish

Slc38a9 Deficiency Induces Apoptosis and Metabolic Dysregulation and Leads to Premature Death in Zebrafish

Strategy of Hepatic Metabolic Defects Induced by Beclin1 Heterozygosity in Adult Zebrafish.

Peroxisomal proliferator-activated receptor -b deficiency induces the reprogramming of nutrient metabolism in zebrafish

Deciphering metabolomics and lipidomics landscape in zebrafish hypertrophic cardiomyopathy model

BSCL2/Seipin deficiency in hearts causes cardiac energy deficit and dysfunction via inducing excessive lipid catabolism

Establishment of a lipid metabolism disorder model in ApoEb mutant zebrafish

Zebrafish and cellular models of -Related Myopathy exhibit novel embryonic and metabolic phenotypes

Downregulation of Adipose Triglyceride Lipase Promotes Cardiomyocyte Hypertrophy by Triggering the Accumulation of Ceramides.

Depletion of Zebrafish Essential and Regulatory Myosin Light Chains Reduces Cardiac Function Through Distinct Mechanisms

Hepatic extracellular ATP/adenosine dynamics in zebrafish models of alcoholic and metabolic steatotic liver disease